Skip to Main Content

Revita T2Di Study

Conditions

Diabetes Mellitus - Type 2 | Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum

What is the purpose of this trial?

The purpose of this research study is to learn more about the use of the Fractyl Revita System for the treatment of Type 2 diabetes for patients who are on insulin therapy. Researchers are testing a new method, Duodenal mucosal resurfacing (DMR), which is a novel, minimally invasive, upper endoscopic procedure involving heating of the duodenal mucosa as a form of treatment for patients with type 2 Diabetes. You will be randomized to either Sham or DMR Procedure, with the opportunity to cross-over to the DMR procedure at the completion of the study. The study will last 2 years, with a total of 16 visits compensating at $100 per visit.

  • Trial with
    Fractyl Laboratories, Inc.
  • Start Date
    09/15/2021
  • End Date
    05/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/23/2021
  • Study HIC
    #2000029448